SNP information rs2745557

Research and publications:

  17609663   COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.

  18038187   Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma.

  18085997   Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance.

  18579107   Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios.

  18682823   Canadian Urological Association, 63rd Annual Meeting, Edmonton, AB, June 22-25, 2008.

  18768181   Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study.

  19318492   Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk.

  19437564   No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.

  19505919   Toll-like receptor signaling pathway variants and prostate cancer mortality

  19560328   No association between the PPARG gene and schizophrenia in a British population.

  19755647   Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

  19776642   Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer.

  19820421   The effect of genetic polymorphisms of cyclooxygenase 2 on acute pancreatitis in Turkey.

  19965896   PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)

  20034614   Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels

  20621252   The genetics of vascular complications in diabetes mellitus.

  20676755   Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.

  20688905   Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.

  21063235   PharmGKB summary: very important pharmacogene information for PTGS2.

  21430300   Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.

  21532843   Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk.

  21705955   Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility.

  22376259   Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.

  22435969   Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis.

  22551325   No association of nineteen COX-2 gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study.

  22824134   Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients.

  23272139   Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.

  25368279   Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.

  26920155   Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.

  26967244   Systematic meta-analyses of gene-specific genetic association studies in prostate cancer.

  27647999   Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.

  32100450   Association between COX-2 and 15-PGDH polymorphisms and SLE susceptibility.

  33545665   Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohort.

  33565113   Connection of COX-2 variants to ankylosing spondylitis susceptibility.

  35430434   Polymorphisms of COX/PEG2 pathway-related genes are associated with the risk of lung cancer: A case-control study in China.